Literature DB >> 20650890

Loss of beta1-integrin enhances TGF-beta1-induced collagen expression in epithelial cells via increased alphavbeta3-integrin and Rac1 activity.

Tomoko Hayashida1, Jonathan C R Jones, Carrie K Lee, H William Schnaper.   

Abstract

Transforming growth factor β (TGF-β) promotes tissue fibrosis via the receptor-specific Smad pathway and non-canonical pathways. We recently reported that TGF-β1-stimulated collagen expression by cultured kidney cells requires integrin-dependent activation of focal adhesion kinase (FAK) and consequent ERK MAP kinase activity leading to Smad3 linker region phosphorylation. Here, we defined a role for αvβ3-integrin in this non-canonical pathway. A human kidney tubular cell line in which β1-integrin was knocked down (β1-k/d) demonstrated enhanced type I collagen mRNA expression and promoter activity. A second shRNA to either αv-integrin or β3-integrin, but not to another αv-binding partner, β6-integrin, abrogated the enhanced COL1A2 promoter activity in β1-k/d cells. Although αvβ3-integrin surface expression levels were not different, αvβ3-integrins colocalized with sites of focal adhesion significantly more in β1-k/d cells, and activated αvβ3-integrin was detected only in β1-k/d cells. Further, the collagen response was decreased by a function-blocking antibody or a peptide inhibitor of αvβ3-integrin. In cells lacking αvβ3-integrin, the responses were attenuated, whereas the response was enhanced in αvβ3-overexpressing cells. Rac1 and ERK, previously defined mediators for this non-canonical pathway, showed increased activities in β1-k/d cells. Finally, inhibition of αvβ3-integrin decreased Rac1 activity and COL1A2 promoter activity in β1-k/d cells. Together, our results indicate that decreasing β1 chain causes αvβ3-integrin to become functionally dominant and promotes renal cell fibrogenesis via Rac1-mediated ERK activity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20650890      PMCID: PMC2945568          DOI: 10.1074/jbc.M110.105700

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  52 in total

Review 1.  Cell adhesion molecules and the glomerulopathies.

Authors:  S Adler; H R Brady
Journal:  Am J Med       Date:  1999-10       Impact factor: 4.965

2.  Beta1-integrin orients epithelial polarity via Rac1 and laminin.

Authors:  Wei Yu; Anirban Datta; Pascale Leroy; Lucy Erin O'Brien; Grace Mak; Tzuu-Shuh Jou; Karl S Matlin; Keith E Mostov; Mirjam M P Zegers
Journal:  Mol Biol Cell       Date:  2004-12-01       Impact factor: 4.138

3.  Accelerated re-epithelialization in beta3-integrin-deficient- mice is associated with enhanced TGF-beta1 signaling.

Authors:  L E Reynolds; F J Conti; M Lucas; R Grose; S Robinson; M Stone; G Saunders; C Dickson; R O Hynes; A Lacy-Hulbert; K Hodivala-Dilke
Journal:  Nat Med       Date:  2005-01-16       Impact factor: 53.440

4.  Cell lines with extended in vitro growth potential from human renal proximal tubule: characterization, response to inducers, and comparison with established cell lines.

Authors:  L C Racusen; C Monteil; A Sgrignoli; M Lucskay; S Marouillat; J G Rhim; J P Morin
Journal:  J Lab Clin Med       Date:  1997-03

5.  Elevated levels of the alpha 5 beta 1 fibronectin receptor suppress the transformed phenotype of Chinese hamster ovary cells.

Authors:  F G Giancotti; E Ruoslahti
Journal:  Cell       Date:  1990-03-09       Impact factor: 41.582

6.  Transforming growth factor beta stimulates the expression of fibronectin and of both subunits of the human fibronectin receptor by cultured human lung fibroblasts.

Authors:  C J Roberts; T M Birkenmeier; J J McQuillan; S K Akiyama; S S Yamada; W T Chen; K M Yamada; J A McDonald
Journal:  J Biol Chem       Date:  1988-04-05       Impact factor: 5.157

7.  The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells.

Authors:  A C Poncelet; M P de Caestecker; H W Schnaper
Journal:  Kidney Int       Date:  1999-10       Impact factor: 10.612

Review 8.  Focal adhesion kinase: in command and control of cell motility.

Authors:  Satyajit K Mitra; Daniel A Hanson; David D Schlaepfer
Journal:  Nat Rev Mol Cell Biol       Date:  2005-01       Impact factor: 94.444

9.  Selective alpha v beta 3 integrin blockade potently limits neointimal hyperplasia and lumen stenosis following deep coronary arterial stent injury: evidence for the functional importance of integrin alpha v beta 3 and osteopontin expression during neointima formation.

Authors:  S S Srivatsa; L A Fitzpatrick; P W Tsao; T M Reilly; D R Holmes; R S Schwartz; S A Mousa
Journal:  Cardiovasc Res       Date:  1997-12       Impact factor: 10.787

10.  Human Smad3 and Smad4 are sequence-specific transcription activators.

Authors:  L Zawel; J L Dai; P Buckhaults; S Zhou; K W Kinzler; B Vogelstein; S E Kern
Journal:  Mol Cell       Date:  1998-03       Impact factor: 17.970

View more
  15 in total

1.  Integrin-mediated type II TGF-β receptor tyrosine dephosphorylation controls SMAD-dependent profibrotic signaling.

Authors:  Xiwu Chen; Hongtao Wang; Hong-Jun Liao; Wen Hu; Leslie Gewin; Glenda Mernaugh; Sheng Zhang; Zhong-Yin Zhang; Lorenzo Vega-Montoto; Roberto M Vanacore; Reinhard Fässler; Roy Zent; Ambra Pozzi
Journal:  J Clin Invest       Date:  2014-07-01       Impact factor: 14.808

Review 2.  Cell-matrix adhesion of podocytes in physiology and disease.

Authors:  Norman Sachs; Arnoud Sonnenberg
Journal:  Nat Rev Nephrol       Date:  2013-01-22       Impact factor: 28.314

3.  Podocyte injury-driven intracapillary plasminogen activator inhibitor type 1 accelerates podocyte loss via uPAR-mediated β1-integrin endocytosis.

Authors:  Namiko Kobayashi; Toshiharu Ueno; Kumi Ohashi; Hanako Yamashita; Yukina Takahashi; Kazuo Sakamoto; Shun Manabe; Satoshi Hara; Yasutoshi Takashima; Takashi Dan; Ira Pastan; Toshio Miyata; Hidetake Kurihara; Taiji Matsusaka; Jochen Reiser; Michio Nagata
Journal:  Am J Physiol Renal Physiol       Date:  2015-01-13

4.  Lung-specific loss of the laminin α3 subunit confers resistance to mechanical injury.

Authors:  Daniela Urich; Jessica L Eisenberg; Kevin J Hamill; Desire Takawira; Sergio E Chiarella; Saul Soberanes; Angel Gonzalez; Frank Koentgen; Tomas Manghi; Susan B Hopkinson; Alexander V Misharin; Harris Perlman; Gokhan M Mutlu; G R Scott Budinger; Jonathan C R Jones
Journal:  J Cell Sci       Date:  2011-09-01       Impact factor: 5.285

Review 5.  Matrix-dependent perturbation of TGFβ signaling and disease.

Authors:  Jefferson J Doyle; Elizabeth E Gerber; Harry C Dietz
Journal:  FEBS Lett       Date:  2012-05-26       Impact factor: 4.124

6.  Deletion of β1-integrin in collecting duct principal cells leads to tubular injury and renal medullary fibrosis.

Authors:  Fahmy A Mamuya; Dongping Xie; Lei Lei; Ming Huang; Kenji Tsuji; Diane E Capen; BaoXue Yang; Ralph Weissleder; Teodor G Păunescu; Hua A Jenny Lu
Journal:  Am J Physiol Renal Physiol       Date:  2017-07-12

7.  Serine-204 in the linker region of Smad3 mediates the collagen-I response to TGF-β in a cell phenotype-specific manner.

Authors:  J A Browne; X Liu; H W Schnaper; T Hayashida
Journal:  Exp Cell Res       Date:  2013-09-27       Impact factor: 3.905

8.  Beta 1 integrin predicts survival in breast cancer: a clinicopathological and immunohistochemical study.

Authors:  Petra Barros dos Santos; Juliana S Zanetti; Alfredo Ribeiro-Silva; Eduardo I C Beltrão
Journal:  Diagn Pathol       Date:  2012-08-16       Impact factor: 2.644

9.  Divergent roles of Smad3 and PI3-kinase in murine adriamycin nephropathy indicate distinct mechanisms of proteinuria and fibrogenesis.

Authors:  Gal Finer; H William Schnaper; Yashpal S Kanwar; Xiaoyan Liang; Herbert Y Lin; Tomoko Hayashida
Journal:  Kidney Int       Date:  2012-04-25       Impact factor: 10.612

10.  Serial non-invasive monitoring of renal disease following immune-mediated injury using near-infrared optical imaging.

Authors:  Yong Du; Shion An; Li Liu; Li Li; Xin J Zhou; Ralph P Mason; Chandra Mohan
Journal:  PLoS One       Date:  2012-09-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.